<DOC>
	<DOCNO>NCT00844753</DOCNO>
	<brief_summary>The study evaluate effectiveness atomoxetine ( Strattera ) without Parent Management Training ( PMT ) child Autism , Asperger 's Disorder , Pervasive Developmental Disorder Not Otherwise Specified ( PDDNOS ) symptoms Attention Deficit Hyperactivity Disorder ( ADHD ) . This double-blind placebo , parallel study atomoxetine dose titration 6 week period . All child see weekly titration period , additional visit Week 8 Week 10 . Families assign PMT arm additional weekly meeting clinician total 9 PMT visit . PMT involve teach parent implement behavioral intervention child . Subjects clinical responder ( ADHD Responders Compliance Responders ) 10 week study period follow every 4 week 24-week extension study . Subjects clinical nonresponders continue PMT receive PMT double-blind phase , receive open trial atomoxetine placebo double-blind phase . All subject ( responder nonresponders ) invite participate follow-up assessment every 4 week 24 week completion double-blind phase .</brief_summary>
	<brief_title>Atomoxetine , Placebo Parent Management Training Autism</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Asperger Syndrome</mesh_term>
	<mesh_term>Child Development Disorders , Pervasive</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Children 5 yr 14 year 11 mos clinical diagnosis Autism , Asperger 's Disorder , PDDNOS base upon ADIR clinical evaluation DSMIV criterion , Mental age equal great 24 month , ADHD symptom base upon CASI clinical confirm diagnosis , CGISS rating 4 grater ADHD symptom , A mean item score &gt; 1.5 Parent Teacher ( nonparent caregiver ) SNAPIV 18 ADHD symptom 9symptom hyperactiveimpulsive subscale ( symptom must crosssituational ) , Reliable care provider available bring subject clinic visit weekly session . DSMIV diagnosis schizophrenia , schizoaffective disorder psychotic disorder NOS , bipolar disorder , major depression ( accompany family history bipolar disorder ) base upon evidence suicidality , CASI , clinical interview/history , Prior fail adequate trial atomoxetine , Use psychotropic medication produce CNS effect , Diagnosis bipolar disorder , major depression , hypertension , cardiovascular disease , narrow angle glaucoma , significant physical illness , Pregnancy sexually active female ( intercourse past 6 month , report either subject caregiver ) , Currently effective medication treatment ADHD , Prior involvement Parent Management Training similar program , Currently albuterol take beta blocker , Taking supplement complementary medical treatment dose hold current level duration study</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Autism</keyword>
	<keyword>PDD NOS</keyword>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>Parent Management Training</keyword>
</DOC>